Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Transoral robotic surgery (TORS) for the diagnosis of head and neck cancer of unknown primary

Title

Output Type

Speciality

Published

Title

Transoral robotic surgery (TORS) for the diagnosis of head and neck cancer of unknown primary

Output Type

Advice Statement

Speciality

Cancer, Ear, nose and throat

Published

18 January 2018

Recommendation for NHSScotland

Head and neck cancer of unknown primary (HNCUP) is a relatively rare condition affecting less than 5% of head and neck cancer patients. Evidence on the use of transoral robotic surgery (TORS) in patients with HNCUP was limited to three small non-comparative studies.

No firm conclusions could be drawn about the effectiveness of TORS mucosectomy/lingual tonsillectomy in patients with HNCUP due to a lack of studies directly comparing TORS with blind biopsy.

No cost-effectiveness evidence was identified on TORS in patients with HNCUP.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What were we asked to look at?

Da Vinci robotic surgical devices are a relatively new technology which is available at three centres in NHSScotland. These devices are currently used predominantly to provide a laparoscopic prostatectomy service. To ensure the devices are optimally employed, NHSScotland is considering expanding the indications for which robotic surgery is available.

Why is this important?

This work was accepted onto the SHTG programme as a priority to support evidence-informed use of robotic surgery capacity.

Referred by

West of Scotland Cancer Network

Download icon
Download Advice
pdf (464 KB)
Download icon
Download Evidence Note
pdf (464 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?